Package 0310-4600-12

Brand: bevespi aerosphere

Generic: glycopyrrolate and formoterol fumarate
NDC Package

Package Facts

Identity

Package NDC 0310-4600-12
Digits Only 0310460012
Product NDC 0310-4600
Product ID 0310-4600_90a24746-75fb-490b-9e0d-7e33a5d8f00a
Description

120 AEROSOL, METERED in 1 INHALER (0310-4600-12)

Marketing

Marketing Status
Marketed Since 2016-10-03
Brand bevespi aerosphere
Generic glycopyrrolate and formoterol fumarate
Sample Package No

Linked Drug Pages (1)

BEVESPI AEROSPHERE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "90a24746-75fb-490b-9e0d-7e33a5d8f00a", "openfda": {"unii": ["W34SHF8J2K", "V92SO9WP2I"], "rxcui": ["1790639", "1790644"], "spl_set_id": ["ae02436e-9528-490e-a844-0c0f6f2843f9"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 AEROSOL, METERED in 1 INHALER (0310-4600-12)", "package_ndc": "0310-4600-12", "marketing_start_date": "20161003"}], "brand_name": "BEVESPI AEROSPHERE", "product_id": "0310-4600_90a24746-75fb-490b-9e0d-7e33a5d8f00a", "dosage_form": "AEROSOL, METERED", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0310-4600", "generic_name": "Glycopyrrolate and formoterol fumarate", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BEVESPI AEROSPHERE", "active_ingredients": [{"name": "FORMOTEROL FUMARATE", "strength": "4.8 ug/1"}, {"name": "GLYCOPYRROLATE", "strength": "9 ug/1"}], "application_number": "NDA208294", "marketing_category": "NDA", "marketing_start_date": "20161003", "listing_expiration_date": "20261231"}